"We are pleased the Court recognized that Covidien's trocar products are differentiated from our competitors.
http://eon.businesswire.com/news/eon/20130829006101/en/Covidien-Prevails-Patent-Action-Applied-Medical-Resources
http://eon.businesswire.com/news/eon/20130829006101/en/Covidien-Prevails-Patent-Action-Applied-Medical-Resources
No comments:
Post a Comment